title: Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure?
abstract: The overall role of modification of β-cell antigens in type 1 diabetes has not been elucidated and was the focus of a recent workshop on posttranslational modification of proteins in type 1 diabetes. The prevailing opinion of the workshop attendees was that novel insights into the mechanism of loss of immune tolerance might be gained and that novel diagnostic and therapeutic approaches could be developed for type 1 diabetes if protein modifications were shown to play a critical role in the disease.
authors: Juvenile Diabetes Research Foundation, New York, New York, USA. jdunne@jdrf.org
authors: Jessica L
authors: JL
authors: Dunne
authors: Lut
authors: L
authors: Overbergh
authors: Anthony W
authors: AW
authors: Purcell
authors: Chantal
authors: C
authors: Mathieu
mesh_terms: D017951:Antigen Presentation / Q000502:physiology; D000941:Antigens / Q000276:immunology / Q000378:metabolism*; D001324:Autoantigens / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D050417:Insulin-Secreting Cells / Q000276:immunology* / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D011506:Proteins / Q000378:metabolism*
chemical_list: D000941:Antigens; D001324:Autoantigens; D015415:Biomarkers; D011506:Proteins